Three components for treating the unhealthy, uncompetitive U.S. health care market — beginning with a buyer’s revolt.
Competition in Health Care
The health care industry is changing rapidly, and not just the market for medical insurance. How does competition affect the health care market as organizations vie for the best quality and the lowest health care costs?
Article by Jeffrey S. Berns, Aaron Glickman & Matthew S. McCoy
Despite potential benefits, joint ventures between nephrologists and dialysis companies raise legal and ethical concerns because of participants’ conflicts of interest and lack of transparency.
Article by John D. Birkmeyer
A perspective on the growth of NPPs and the ideological divide between for-profit and nonprofit providers.
Article by Ateev Mehrotra, David Schleifer, Amy Shefrin & Andrea M. Ducas
What policymakers, providers, and payers need to do to make price transparency successful.
Article by Dan Liljenquist, Ge Bai & Gerard F. Anderson
A consortium of hospitals and health plans is establishing a nonprofit generic-drug manufacturer to produce a steady supply of affordable essential drugs and stimulate competition in generic-drug markets.
Article by William H. Shrank, Diane Holder & Steven D. Shapiro
UPMC’s payer-provider partnership integrates real-time data to support improved clinical decision-making and optimizes clinical and financial performance.
Interview by Robert Galvin & Leemore Dafny
Will Amazon–Berkshire Hathaway–JP Morgan and CVS-Aetna change the health care game? To one health care employer purchaser, these announcements feel a lot like Groundhog Day.
Interview by Fiona Scott Morton & Thomas H. Lee
We have to think about how much we want to spend on health according to how much it’s worth to us at the margin.